(Q34798030)

4 August 2017

Natural history and treatment effects in Guillain-Barré syndrome: a multicentre study (English)

1 reference

multicenter clinical trial

4 August 2017

0 references

Guillain–Barré syndrome

0 references

author name string

Korinthenberg R

series ordinal

1

1 reference

PubMed ID

8669925

4 August 2017

Mönting JS

series ordinal

2

1 reference

PubMed ID

8669925

4 August 2017

language of work or name

English

0 references

publication date

1 April 1996

1 reference

Archives of Disease in Childhood

4 August 2017

1 reference

4 August 2017

74

1 reference

4 August 2017

4

1 reference

4 August 2017

281-287

1 reference

Acute renal failure resulting from intravenous immunoglobulin therapy

4 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511471

Epidemiology of Guillain-Barré syndrome in children: relationship of oral polio vaccine administration to occurrence

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511471

The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511471

Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part II.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511471

High-dose intravenous immunoglobulin in the treatment of Guillain-Barré syndrome: a preliminary open study.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511471

Prognosis in Guillain-Barré syndrome

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511471

A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511471

The natural history of the Guillain-Barré syndrome in 18 children and 50 adults

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511471

The role of plasmapheresis in childhood Guillain-Barré syndrome

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511471

Benefit of intravenously administered immune serum globulin in patients with Guillain-Barré syndrome

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511471

Assessment of current diagnostic criteria for Guillain-Barré syndrome

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511471

Occurrence, clinical manifestations, and prognosis of Guillain-Barré syndrome

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511471

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511471

Age-associated changes in the symptomatology of Guillain-Barré syndrome in children

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511471

Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511471

The Guillain-Barré syndrome

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511471

Guillain-Barré syndrome in childhood. Characteristic course and therapeutic possibilities

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511471

Experiences with high dosage immunoglobulin G in neuromuscular diseases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511471

The use of intravenous immunoglobulin in Miller Fisher syndrome.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511471

Childhood Guillain-Barré syndrome in Paraguay, 1990 to 1991.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511471

Guillain-Barré syndrome in children: a cooperative study in Taiwan

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511471

Intravenous Immune Globulin versus Plasma Exchange in Guillain–Barré Syndrome

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511471

Immunoglobulins in the treatment of Guillain-Barré syndrome in early childhood

9 December 2018

1 reference

12 December 2020

Aseptic meningitis associated with high dose intravenous immunoglobulin therapy

1 reference

12 December 2020

A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group

1 reference

12 December 2020

Guillain-Barré syndrome in children: clinical course, electrodiagnosis, and prognosis

1 reference

12 December 2020

[Use of intravenous immunoglobulins in Guillain-Barré syndrome]

1 reference

12 December 2020

Subacute demyelinating polyneuropathy responding to corticosteroid treatment

1 reference

12 December 2020

[Acute polyradiculoneuritis (Guillain-Barré syndrome) in childhood]

1 reference

12 December 2020

Experiences with Guillain-Barré syndrome in a pediatric intensive care unit

1 reference

12 December 2020

Treatment of Guillain-Barré syndrome with high-dose gammaglobulin

1 reference

12 December 2020

Intravenous immunoglobulin in two children with Guillain-Barré syndrome

1 reference

12 December 2020

Human immune globulin infusion in Guillain-Barré syndrome: worsening during and after treatment

1 reference

12 December 2020

Relapse in Guillain-Barré syndrome after treatment with human immune globulin

1 reference

12 December 2020

Demonstration of Borrelia burgdorferi infection in a child with Guillain-Barré syndrome

1 reference

12 December 2020

Intravenous immune globulin is also an efficient therapy of acute Guillain-Barré syndrome in affected children

1 reference

12 December 2020

Intravenous immunoglobulin versus plasma exchange in Guillain-Barré syndrome

1 reference

12 December 2020

High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events

1 reference

12 December 2020

Plasmapheresis vs intravenous immunoglobulin treatment in childhood Guillain-Barré syndrome

1 reference

12 December 2020

Guillain-Barré syndrome: the evolution of therapy

1 reference

12 December 2020

Intravenous immune globulin in children with Guillain-Barré syndrome

1 reference

12 December 2020

Plasma exchange in childhood Guillain-Barré syndrome

1 reference

12 December 2020

Intravenous immunoglobulin treatment in children with Guillain-Barre syndrome

1 reference

12 December 2020

Single-dose intravenous immune globulin for treatment of Guillain-Barré syndrome

1 reference

12 December 2020

Identifiers

DOI

10.1136/ADC.74.4.281

1 reference

4 August 2017

1 reference

4 August 2017

1 reference

PubMed ID

8669925